Evaluation of myocardial perfusion and function after kidney transplantation by Gated SPECT myocardial perfusion scintigraphy

Document Type : Original Article


1 Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran

2 Hasheminejad Kidney Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Nuclear Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

4 Nuclear Medicine Department, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran


Introduction: The aim of this study was to evaluate the effect of successful kidney transplantation (KT) on myocardial perfusion and left ventricular function by both qualitative (visual) interpretation and semiquantitative parameters, using myocardial perfusion scintigraphy with gated-single photon emission computed tomography (gated-SPECT) in patients suffering from end-stage renal disease.
Methods: From a total of 38 patients who were candidates of KT, twenty-six patients (16 female, 10 male, mean age: 47.5 yr, range: 24-64 yr) who had successful KT were included. Myocardial perfusion scintigraphy was performed by Gated Single Photon Emission Computed Tomography (Gated-SPECT) method, before and after surgery (mean: 24 months).  Perfusion and function status was evaluated by qualitative and semiquantitative parameters.
Results: Our data showed qualitative evidence of perfusion and functional abnormality in pre-transplant scans as follows: Abnormal perfusion in left anterior descending (LAD), left circumflex (LCX) and right coronary artery (RCA) territories in 42.5%, 53.8% and 65.4% of cases, respectively; dilation in 57.7% and inhomogenity of uptake in 53.8% of cases. However no statistically significant change was noted after transplantation, i.e. p value for all semiquantitative values including summed stress score (SSS), summed rest score (SRS) and summed difference score (SDS), summed motion score (SMS), summed thickening score (STS), ejection fraction (EF), end diastolic volume (EDV), end systolic volume (ESV), and stroke volume (SV)  was greater than 0.05.

Conclusion: Renal transplantation may not have considerable long term effect on myocardial perfusion and function in patients with chronic renal failure. This could be due to either non-reversible myocardial changes or continuing effect of degrading factors on the myocardium.


Main Subjects

Hung J, Harris PJ, Uren RF, Tiller DJ, Kelly DT. Uremic cardiomyopathy--effect of hemodialysis on left ventricular function in end-stage renal failure. N Engl J Med. 1980 Mar 6;302(10):547-51.
McIntyre CW. Haemodialysis-induced myocardial stunning in chronic kidney disease - a new aspect of cardiovascular disease. Blood Purif. 2010;29(2):105-10.
Sahagún-Sánchez G, Espinola-Zavaleta N, Lafragua-Contreras M, Chávez PY, Gómez-Núñez N, Keirns C, Romero-Cardenas A, Pérez-Grovas H, Acosta JH, Vargas-Barrón J. The effect of kidney transplant on cardiac function: an echocardiographic perspective. Echocardiography. 2001 Aug;18(6):457-62.
Wali RK, Wang GS, Gottlieb SS, Bellumkonda L, Hansalia R, Ramos E, Drachenberg C, Papadimitriou J, Brisco MA, Blahut S, Fink JC, Fisher ML, Bartlett ST, Weir MR. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol. 2005 Apr 5;45(7):1051-60.
Paul AK, Nabi HA. Gated myocardial perfusion SPECT: basic principles, technical aspects, and clinical applications. J Nucl Med Technol. 2004 Dec;32(4):179-87.
Soman P. Gated SPECT myocardial perfusion scintigraphy: a multi-faceted tool for the evaluation of heart failure. J Nucl Cardiol. 2009 Mar-Apr;16(2):173-5.
Facchin L, Vescovo G, Levedianos G, Zannini L, Nordio M, Lorenzi S, Caturelli G, Ambrosio GB. Left ventricular morphology and diastolic function in uraemia: echocardiographic evidence of a specific cardiomyopathy. Br Heart J. 1995 Aug;74(2):174-9.
Vanholder R, Glorieux G, Lameire N. Uraemic toxins and cardiovascular disease. Nephrol Dial Transplant. 2003 Mar;18(3):463-6.
Zoccali C, Bode-Böger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frölich J, Böger R. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.  Lancet. 2001 Dec 22-29;358(9299):2113-7.
Amann K, Breitbach M, Ritz E, Mall G. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol. 1998 Jun;9(6):1018-22.
Mall G, Huther W, Schneider J, Lundin P, Ritz E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant. 1990;5(1):39-44.
Drüeke T, Le Pailleur C, Meilhac B, Koutoudis C, Zingraff J, Di Matteo J, Crosnier J. Congestive cardiomyopathy in uraemic patients on long term haemodialysis. Br Med J. 1977 Feb 5;1(6057):350-3.
McMahon AC, Vescovo G, Dalla Libera L, Wynne DG, Fluck RJ, Harding SE, Raine AE. Contractile dysfunction of isolated ventricular myocytes in experimental uraemia. Exp Nephrol. 1996 May-Jun;4(3):144-50.
Go V, Bhatt MR, Hendel RC. The diagnostic and prognostic value of ECG-gated SPECT myocardial perfusion imaging. J Nucl Med. 2004 May;45(5):912-21.
Bialostozky D, Leyva M, Villarreal T, Casanova JM, Pérez-Grovas H, Lemus P, Jiménez G, Vallejo E, Jiménez-Angeles L, Herrera J, Altamirano J. Myocardial perfusion and ventricular function assessed by SPECT and Gated-SPECT in end-stage renal disease patients before and after renal transplant. Arch Med Res. 2007 Feb;38(2):227-33.
Patel AD, Abo-Auda WS, Davis JM, Zoghbi GJ, Deierhoi MH, Heo J, Iskandrian AE. Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation. Am J Cardiol. 2003 Jul 15;92(2):146-51.
Lewis MS, Wilson RA, Walker KW, Wilson DJ, Norman DJ, Barry JM, Bennett WM. Validation of an algorithm for predicting cardiac events in renal transplant candidates. Am J Cardiol. 2002 Apr 1;89(7):847-50.
Hage FG, Smalheiser S, Zoghbi GJ, Perry GJ, Deierhoi M, Warnock D, Iskandrian AE, de Mattos AM, Aqel RA. Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation. Am J Cardiol. 2007 Sep 15;100(6):1020-5.
Garcheva M, Dzhorgova Iu, Nikolov G. Gated SPECT myocardial perfusion stress scintigraphy for evaluation of the ischemic risk in coronary artery disease. Khirurgiia (Sofiia). 2007;(3):19-24.
Stokkel M, Duchateau CS, Jukema W, de Fijter HW. Noninvasive assessment of left ventricular function prior to and 6 months after renal transplantation. Transplant Proc. 2007 Dec;39(10):3159-62.
Parfrey PS, Harnett JD, Foley RN, Kent GM, Murray DC, Barre PE, Guttmann RD. Impact of renal transplantation on uremic cardiomyopathy. Transplantation. 1995 Nov 15;60(9):908-14.
Seyahi N, Kahveci A, Cebi D, Altiparmak MR, Akman C, Uslu I, Ataman R, Tasci H, Serdengecti K. Coronary artery calcification and coronary ischaemia in renal transplant recipients.  Nephrol Dial Transplant. 2011 Feb;26(2):720-6. 
Diaz G, O'Connor M. Cardiovascular and renal complications in patients receiving a solid-organ transplant.  Curr Opin Crit Care. 2011 Aug;17(4):382-9.